Alpa Laboratories Limited (NSE:ALPA)

India · Delayed Price · Currency is INR

61.00

-1.62 (-2.59%)

Sep 11, 2026, 3:29 PM IST

Market Cap	1.30B -34.8%
Revenue (ttm)	1.11B +0.5%
Net Income	42.22M -83.9%
EPS	2.11 -83.2%
Shares Out	21.04M
PE Ratio	29.23
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,435
Open	62.93
Previous Close	62.62
Day's Range	61.00 - 63.20
52-Week Range	46.10 - 97.51
Beta	0.90
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1988

Employees 453

Stock Exchange National Stock Exchange of India

Ticker Symbol ALPA

Full Company Profile

Financial Performance

In fiscal year 2026, Alpa Laboratories's revenue was 1.06 billion, a decrease of -5.91% compared to the previous year's 1.12 billion. Earnings were 150.10 million, a decrease of -23.04%.

Financial Statements